Key2Brain AB
559239-8746ActiveDeveloping proprietary technology for next-generation brain targeting therapeutics.
Oversikt
- 10–19
- Ansatte
- 2.5–5mill SEK
- Omsetning
- 2020
- Grunnlagt
Beskrivelse
Key2Brain is a Swedish biotechnology company focused on developing next-generation therapies designed to treat severe diseases affecting the brain. Their core offering is a groundbreaking proprietary technology platform engineered to facilitate efficient uptake and broad distribution of therapeutics...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559239874601
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAAX Biotech AB
5–9 ansatteResearch-driven biotech advancing antibody therapies via proprietary technology.
IRLAB Therapeutics AB
1–4 ansatteDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Affibody AB
50–99 ansatteDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Uppsala Therapeutics AB
0 ansatteDeveloping nanoparticle platforms for targeted drug delivery across the BBB.
Grespo AB
0 ansatteYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Utforsk mer
Spørsmål om Key2Brain AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo